Delivery Order SPE2DB22D3016-SPE2DB25FBFT3
Award Date 8/21/25
Potential Completion Date 8/22/25
Potential Value $112K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency for the supply of Atovaquone-Proguanil 250-100 mg tablets (100 count) valued at $517,676.25. The award is a firm fixed price contract with an ultimate completion date of August 22, 2025, and was competitively awarded with no set-aside designation. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and primary distribution hub...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $29,492.33 by the Defense Logistics Agency's Medical Supply Chain for the supply of Atovaquone-Proguanil 250-100 tablets (100 count) with a firm fixed price arrangement. The award, issued on August 14, 2025, carries an ultimate completion date of August 15, 2025, and was competitively awarded without a set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $2,248.56 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 tablets (100-count supply). The contract, which is firm fixed price with no set-aside designation, was awarded on August 18, 2025, and is scheduled for completion by August 19, 2025. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,029.48 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 tablets (100-count units) with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, issued on August 1, 2025, represents a non-set-aside, competitively awarded contract utilizing AmerisourceBergen's established indefinite delivery contract with DLA Troop Support Medical (SPE2DX, valued at $999.99 billion...
- The Defense Logistics Agency awarded a delivery order valued at $1,100.20 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Atovaquone-Proguanil 250-100 (100 tablets). This is a firm fixed-price delivery order with no set-aside designation, demonstrating that the award was competitively procured. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order is issued under...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $2,814.87 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 tablets (100-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with the Defense...
- The Defense Logistics Agency has awarded a firm fixed price delivery order contract worth $56,760.00 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of 4,563,628,854 units of Atovaquone-Proguanil 250-100 mg tablets to support military treatment programs. This delivery order is issued under a larger $999,999,999.00 indefinite delivery contract held by Amerisourcebergen Drug Corp as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.35 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract was awarded on August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The antimalarial medication will support federal medical supply requirements, likely for military personnel...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Atovaquone-Proguanil 250-100 in a quantity of 100 units, with a ceiling value of $4,882.70. This award utilized firm fixed price pricing and is classified as a non-set-aside competitive procurement. The delivery order is contingent upon completion by August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,245.97 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 (100 tablets), a antimalarial medication used primarily for malaria prophylaxis and treatment in military personnel. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...